Target intelligence / Profile preview

Alpha-2 Adrenergic Receptor (α2-AR)

Target
α2-AR
Molecular classification
G protein-coupled receptor (GPCR), Receptor, Adrenergic Receptor, Neurotransmitter Receptor
01

Overview

The alpha-2 (α2) adrenergic receptor is a G protein-coupled receptor (GPCR) that primarily couples to the Gi class of heterotrimeric G-proteins. It plays a key role in modulating neurotransmitter release, vascular tone, and several central nervous system functions by responding to endogenous catecholamines such as norepinephrine and epinephrine. There are three main subtypes: α2A, α2B, and α2C. Activation inhibits adenylyl cyclase, reducing cAMP levels and resulting in decreased neurotransmitter release, sedation, analgesia, hypotension, and bradycardia. Agonists targeting these receptors have diverse clinical uses, including hypertension management, sedation, ADHD treatment, and muscle spasticity reduction.

Other names
Adrenergic receptor alpha-2Alpha2 adrenergic receptorα2 adrenergic receptorADRA2Alpha-2 Adrenoceptor
02

Mechanism of action

Agonists bind to the α2-AR, activating Gi/o proteins. This inhibits adenylyl cyclase, reducing cAMP levels and leading to decreased neurotransmitter release, sedation, analgesia, and altered vascular tone.

03

Biological functions

Signal transductionRegulation of neurotransmitter releaseRegulation of blood pressureModulation of sympathetic outflowRegulation of intraocular pressureCognitive function modulationVasoconstriction/vasodilation
04

Disease associations

HypertensionAttention Deficit Hyperactivity Disorder (ADHD)GlaucomaDrug withdrawalMuscle spasticityPain
05

Safety considerations

HypotensionBradycardiaSedationRebound hypertension upon withdrawal
06

Interacting drugs

Clonidine

4 more in the full profile.

Beyond the preview

Go deeper on Alpha-2 Adrenergic Receptor (α2-AR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-2 Adrenergic Receptor (α2-AR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call